A detailed history of Neo Ivy Capital Management transactions in Becton Dickinson & CO stock. As of the latest transaction made, Neo Ivy Capital Management holds 7,010 shares of BDX stock, worth $1.6 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
7,010
Holding current value
$1.6 Million
% of portfolio
0.57%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$221.47 - $242.41 $1.55 Million - $1.7 Million
7,010 New
7,010 $1.69 Million
Q4 2023

Feb 23, 2024

SELL
$232.24 - $267.23 $202,513 - $233,024
-872 Reduced 46.98%
984 $240,000
Q3 2023

Nov 29, 2023

BUY
$254.9 - $283.59 $473,094 - $526,343
1,856 New
1,856 $480,000
Q4 2022

Mar 24, 2023

BUY
$218.29 - $256.91 $206,938 - $243,550
948 New
948 $241,000
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $86,979 - $96,561
-357 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$230.08 - $250.94 $82,138 - $89,585
357 New
357 $87,000
Q3 2021

Nov 16, 2021

SELL
$232.72 - $256.47 $207,353 - $228,514
-891 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$232.65 - $254.58 $149,593 - $163,694
-643 Reduced 41.92%
891 $217,000
Q1 2021

Oct 07, 2021

BUY
$232.09 - $256.88 $356,026 - $394,053
1,534 New
1,534 $373,000
Q4 2020

Feb 16, 2021

SELL
$221.92 - $245.94 $274,958 - $304,719
-1,239 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$215.77 - $276.76 $124,715 - $159,967
578 Added 87.44%
1,239 $288,000
Q1 2020

May 15, 2020

BUY
$195.69 - $279.01 $129,351 - $184,425
661 New
661 $152,000
Q2 2019

Aug 15, 2019

SELL
$217.4 - $246.08 $297,403 - $336,637
-1,368 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $281,876 - $339,496
1,368 New
1,368 $341,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.